Clinical Trial Update: Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial explores DNA-typing and erythrocyte microparticle analysis to detect blood doping, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Disease
• Blood Doping
• Blood Transfusion

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Blood Disease, Blood Transfusion, Autologous | Phase 3 | Status: UNKNOWN